# OnCo record anbogen-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/anbogen-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "anbogen-therapeutics" ;
  schema:name "Anbogen Therapeutics"@en ;
  schema:alternateName "安邦生技"@en ;
  schema:description "Anbogen Therapeutics is a Taiwan-based biotechnology company that leads 2 cancer trials in OnCo, testing ABT-101 and ABT-301 in colorectal cancer and non-small-cell lung cancer."@en ;
  schema:url <https://onco.cc/companies/anbogen-therapeutics/>, <https://anbogen.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://anbogen.com/>, <https://clinicaltrials.gov/search?lead=Anbogen%20Therapeutics%2C%20Inc.> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "TW" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/nsclc/> ;
  onco:drugs <https://onco.cc/drugs/abt-301/>, <https://onco.cc/drugs/tislelizumab/>, <https://onco.cc/drugs/bevacizumab/> ;
  onco:trials <https://onco.cc/trials/nct07244705/>, <https://onco.cc/trials/nct05532696/> .